Technology Leader in Ultra High-Frequency Micro-Ultrasound, VisualSonics, Generated $30M in Trailing Twelve Month Revenues and $5M of EBITDAS. Company is a Leader in the $350M Pre-Clinical Imaging Research Market Acquisition Stages Move of Ultra …

VevoCQ™ enables measurement of perfusion kinetics in tumors and other tissue TORONTO, Canada - April 14, 2010  – VisualSonics Inc., the leader in real-time,  in vivo , high-resolution micro-imaging systems, and Bracco Group, the foremost developer and …

Numerous World Renowned Experts Presenting Novel Applications of In Vivo Imaging Using Micro-Ultrasound for Cancer Research Toronto, Ontario. – March 30, 2006 – VisualSonics, the world’s leading developer of high-resolution, ultrasound-based, in vivo …

Company will in-license University of Virginia contrast agent for use in cardiovascular research Toronto, Ontario. – January 26, 2006 – Paving the way for its entry into the molecular imaging market, VisualSonics, the world’s leading developer of …

PARIS and TORONTO - (March 31st, 2009) –  Mauna Kea Technologies and VisualSonics today announced that they have entered an exclusive distribution agreement through which VisualSonics will market and sell Cellvizio LAB high resolution in vivo imaging …

BOTHELL, WA- June 30, 2010 – SonoSite, Inc. (NASDAQ: SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today announced that on June 30, 2010, it completed its acquisition of privately held VisualSonics, a Toronto-based …

Toronto, Ontario. – January 23, 2006 – VisualSonics, the world’s leading developer of high resolution, micro-ultrasound-based in vivo imaging systems for preclinical research, today announced that its quality management system has been registered as …

(Toronto, Canada) October 25, 2007: VisualSonics would like to congratulate Dr. Andrej Lyshchik and Dr. John Gore of Vanderbilt University Medical Center, Nashville, Tennessee, whose paper using the Vevo 770 and MicroMarker Contrast Agents , was selected …

A new dimension of diagnostic information: Strain analysis feature of Vevo ®  2100 high-frequency ultrasound system enables highly sensitive and rapid measurement of global (whole heart) and regional (specific heart areas) cardiac function. TORONTO, …